256 related articles for article (PubMed ID: 30463803)
1. The diagnostic and prognostic significance of long non-coding RNA CRNDE in pan-cancer based on TCGA, GEO and comprehensive meta-analysis.
Hongzhen Z; Yanyu L; Xuexiang L; Meiyu D; Xiaoli C; Yun G; Jingfan C; Shengming D
Pathol Res Pract; 2019 Feb; 215(2):256-264. PubMed ID: 30463803
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA CRNDE as a potential prognostic biomarker in solid tumors: A meta-analysis.
Liang C; Zhang B; Ge H; Xu Y; Li G; Wu J
Clin Chim Acta; 2018 Jun; 481():99-107. PubMed ID: 29501692
[TBL] [Abstract][Full Text] [Related]
3. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer.
Liu T; Zhang X; Gao S; Jing F; Yang Y; Du L; Zheng G; Li P; Li C; Wang C
Oncotarget; 2016 Dec; 7(51):85551-85563. PubMed ID: 27888803
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA CRNDE in cancer prognosis: Review and meta-analysis.
Xie H; Ma B; Gao Q; Zhan H; Liu Y; Chen Z; Ye S; Li J; Yao L; Huang W
Clin Chim Acta; 2018 Oct; 485():262-271. PubMed ID: 30008427
[TBL] [Abstract][Full Text] [Related]
5. Pseudogene DUXAP10 can be used as a diagnostic and prognostic biomarker in human cancers.
Yue C; Ren Y; Ge H; Yan L; Xu Y; Wang G; Wu J
J Cell Physiol; 2019 Dec; 234(12):23685-23694. PubMed ID: 31169303
[TBL] [Abstract][Full Text] [Related]
6. Potential diagnostic and prognostic value of the long non-coding RNA SNHG3 in human cancers: A systematic review and meta-analysis.
Wang D; Zou L; Luo J; Zhang C; Feng H; Qin G
Int J Biol Markers; 2022 Mar; 37(1):3-12. PubMed ID: 35130083
[TBL] [Abstract][Full Text] [Related]
7. Serum exosomal long noncoding RNA CRNDE as a prognostic biomarker for hepatocellular carcinoma.
Wang T; Zhu H; Xiao M; Zhou S
J Clin Lab Anal; 2021 Nov; 35(11):e23959. PubMed ID: 34612554
[TBL] [Abstract][Full Text] [Related]
8. Evaluation on the diagnostic and prognostic values of long non-coding RNA BLACAT1 in common types of human cancer.
Chen X; Dai M; Zhu H; Li J; Huang Z; Liu X; Huang Y; Chen J; Dai S
Mol Cancer; 2017 Oct; 16(1):160. PubMed ID: 29037201
[TBL] [Abstract][Full Text] [Related]
9. Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.
Liao X; Yang C; Huang R; Han C; Yu T; Huang K; Liu X; Yu L; Zhu G; Su H; Wang X; Qin W; Deng J; Zeng X; Ye X; Peng T
Cell Physiol Biochem; 2018; 48(5):1854-1869. PubMed ID: 30092592
[TBL] [Abstract][Full Text] [Related]
10. The prognostic role of long noncoding RNA CRNDE in cancer patients: a systematic review and meta-analysis.
Wang W; Yuan F; Xu J
Neoplasma; 2019 Jan; 66(1):73-82. PubMed ID: 30509091
[TBL] [Abstract][Full Text] [Related]
11. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
12. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
[TBL] [Abstract][Full Text] [Related]
13. Expression of long non-coding RNA CRNDE in glioma and its correlation with tumor progression and patient survival.
Jing SY; Lu YY; Yang JK; Deng WY; Zhou Q; Jiao BH
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):3992-3996. PubMed ID: 27775801
[TBL] [Abstract][Full Text] [Related]
14. LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma.
Ding C; Han F; Xiang H; Xia X; Wang Y; Dou M; Zheng J; Li Y; Xue W; Ding X; Tian P
J Cell Biochem; 2018 Dec; 119(12):10406-10414. PubMed ID: 30129055
[TBL] [Abstract][Full Text] [Related]
15. Identification of a five-lncRNA signature for the diagnosis and prognosis of gastric cancer.
Fan ZY; Liu W; Yan C; Zhu ZL; Xu W; Li JF; Su L; Li C; Zhu ZG; Liu B; Yan M
Tumour Biol; 2016 Oct; 37(10):13265-13277. PubMed ID: 27460075
[TBL] [Abstract][Full Text] [Related]
16. Low microRNA-139 expression associates with poor prognosis in patients with tumors: A meta-analysis.
Chen JA; Yu Y; Xue C; Chen XL; Cui GY; Li J; Li KF; Ren ZG; Sun RR
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):321-331. PubMed ID: 30290990
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA CRNDE may be associated with poor prognosis by promoting proliferation and inhibiting apoptosis of cervical cancer cells through targeting PI3K/AKT.
Yang HY; Huang CP; Cao MM; Wang YF; Liu Y
Neoplasma; 2018 Nov; 65(6):872-880. PubMed ID: 30334449
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Long Noncoding RNA CRNDE as a Novel Biomarker in Solid Cancers: An Updated Systematic Review and Meta-Analysis.
Zhou Y; Wang R; Xu T; Xie P; Zhang Y; Zhang A; Wang X; Yang C; Yang H; Zhu S
J Cancer; 2019; 10(11):2386-2396. PubMed ID: 31258743
[No Abstract] [Full Text] [Related]
19. RNA-Sequencing Data Reveal a Prognostic Four-lncRNA-Based Risk Score for Bladder Urothelial Carcinoma: An in Silico Update.
He RQ; Huang ZG; Li TY; Wei YP; Chen G; Lin XG; Wang QY
Cell Physiol Biochem; 2018; 50(4):1474-1495. PubMed ID: 30359990
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic efficacy of long non-coding RNA in lung cancer: a systematic review and meta-analysis.
Dai SP; Jin J; Li WM
Postgrad Med J; 2018 Oct; 94(1116):578-587. PubMed ID: 30333134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
